ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

ACCC Planning Session Considers Community Impact

August 31, 1979

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Remaining DCT Recompetitions

November 7, 1980

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993